Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2019 Oct 18;6(3):MMT24.
doi: 10.2217/mmt-2019-0011.

An evidence-based approach to positive sentinel node disease: should we ever do a completion node dissection?

Jennifer S Downs  1 , David E Gyorki  1   2   3
Affiliations
Review

An evidence-based approach to positive sentinel node disease: should we ever do a completion node dissection?

Jennifer S Downs et al. Melanoma Manag. .

Abstract

Management of later stage melanoma has undergone significant changes. Sentinel node biopsy has long been an accepted method of staging, but two recent randomized-controlled trials have provided an evidence base for decision making about completion lymphadenectomy. They showed no survival advantage in further surgery for patients with positive sentinel node biopsies. There is now no evidence to support completion lymphadenectomy in the majority of patients, and this is reflected in international practice guidelines.

Keywords: DeCOG-SLT; MSLT-2; lymph node; lymphadenectomy; melanoma; sentinel node.

PubMed Disclaimer

Conflict of interest statement

Financial & competing interests disclosure The authors have no relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript. This includes employment, consultancies, honoraria, stock ownership or options, expert testimony, grants or patents received or pending, or royalties. No writing assistance was utilized in the production of this manuscript.

References

    1. Vito R, Sondak V, Smalley K. A brief history of melanoma: from mummies to mutations. Melanoma Res. 22(2), 114–122 (2013). - PMC - PubMed
    1. Snow H. Abstract of a lecture on melanotic cancerous disease. Lancet 140(3607), 872–874 (1892).
    1. Moody JA, Botham SJ, Dahill KE, Wallace DL, Hardwicke JT. Complications following completion lymphadenectomy versus therapeutic lymphadenectomy for melanoma – a systematic review of the literature. Eur. J. Surg. Oncol. 43(9), 1760–1767 (2017). - PubMed
    1. Balch CM, Soong SJ, Ross MI. et al. Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Ann. Surg. Oncol. 7(2), 87–97 (2000). - PubMed
    1. Cascinelli N, Morabito A, Santinami M, Mackie RM, Belli F. Immediate or delayed dissection of regional nodes in patients with melanoma of the trunk: a randomised trial. Lancet 351(9105), 793–796 (1998). - PubMed

LinkOut - more resources